ENTITY
Peijia Medical

Peijia Medical (9996 HK)

82
Analysis
Health Care • China
Peijia Medical is a China-based company specializing in the research, development, and manufacturing of high-end interventional medical devices. It provides comprehensive treatment solutions for structural heart diseases, including transcatheter aortic valve replacement (TAVR) systems, and neurovascular diseases with various neurointerventional devices. The company was founded in 2012 and is headquartered in Suzhou, China.
more
bullish•JD.com (ADR)
•03 May 2020 13:58

ECM Weekly (3 May 2020) - JD.com, Hangzhou Tigermed, Peijia Medical, Central China New Life

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. The...

Share
bullish•Peijia Medical
•28 Apr 2020 16:50

Peijia Medical (ę²›å˜‰åŒ»ē–—) Pre-IPO: Deserves Valuation Premium for the TAVR Late Comer

Peijia Medical is a leading domestic player in the transcatheter valve therapeutic medical device market and the neurointerventional procedural...

Logo
654 Views
Share
bullish•Peijia Medical
•28 Apr 2020 00:10

Peijia Medical IPO Initiation: Let's Have a Heart-To-Heart

Peijia Medical (1740651D CH) is a leading transcatheter heart valve medical device company in China. It has filed for a Hong Kong IPO and is...

Logo
486 Views
Share
bullish•Kingsoft Cloud
•26 Apr 2020 12:44

ECM Weekly (26 Apr 2020) - Kingsoft Cloud, WeDoctor, Akesobio, Kotak Mahindra Bank

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Akeso...

Share
bullish•Peijia Medical
•18 Feb 2020 10:34

Peijia Medical (ę²›å˜‰åŒ»ē–—) Pre-IPO: Reminiscence of Venus Medtech?

Peijia Medical is a leading domestic player in the transcatheter valve therapeutic medical device market and the neurointerventional procedural...

Logo
1.4k Views
Share
x